BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12170409)

  • 1. Treatment of unresectable pancreatic carcinoma by intraluminal brachytherapy in the duct of Wirsung.
    Mutignani M; Shah SK; Morganti AG; Perri V; Macchia G; Costamagna G
    Endoscopy; 2002 Jul; 34(7):555-9. PubMed ID: 12170409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraluminal brachytherapy in the treatment of pancreas and bile duct carcinoma.
    Montemaggi P; Costamagna G; Dobelbower RR; Cellini N; Morganti AG; Mutignani M; Perri V; Brizi G; Marano P
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):437-43. PubMed ID: 7538501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of intraluminal brachytherapy in extrahepatic bile duct and pancreatic cancers: is it just for palliation?
    Montemaggi P; Morganti AG; Dobelbower RR; Brizi G; Smaniotto D; Costamagna G; Cellini N; Marano P
    Radiology; 1996 Jun; 199(3):861-6. PubMed ID: 8638018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II study.
    Nori D; Merimsky O; Osian AD; Heffernan M; Cortes E; Turner JW
    J Surg Oncol; 1996 Apr; 61(4):300-5. PubMed ID: 8628003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
    Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
    Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
    Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results.
    Deodato F; Clemente G; Mattiucci GC; Macchia G; Costamagna G; Giuliante F; Smaniotto D; Luzi S; Valentini V; Mutignani M; Nuzzo G; Cellini N; Morganti AG
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):483-8. PubMed ID: 16242254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas.
    Maire F; Hammel P; Ponsot P; Aubert A; O'Toole D; Hentic O; Levy P; Ruszniewski P
    Am J Gastroenterol; 2006 Apr; 101(4):735-42. PubMed ID: 16635221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraluminal implantation of radioactive stents for treatment of primary carcinomas of the peripancreatic-head region: a pilot study.
    Liu Y; Lu Z; Zou DW; Jin ZD; Liu F; Li SD; Zhan XB; Zhang WJ; Wu RP; Yao YZ; Yang L; Li Z
    Gastrointest Endosc; 2009 May; 69(6):1067-73. PubMed ID: 19243771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome.
    Milano MT; Chmura SJ; Garofalo MC; Rash C; Roeske JC; Connell PP; Kwon OH; Jani AB; Heimann R
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):445-53. PubMed ID: 15145161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transduodenal intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region.
    Dvorák J; Petera J; Papík Z; Melichar B; Vanásek T; Hulek P; Jandík P; Mergancová J; Zoul Z; Vacek Z
    Hepatogastroenterology; 2002; 49(46):1045-7. PubMed ID: 12143198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
    Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
    Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
    Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer.
    Nomura M; Yamakado K; Nomoto Y; Nakatsuka A; Ii N; Shoji K; Takeda K
    Int J Oncol; 2002 Feb; 20(2):325-31. PubMed ID: 11788896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study.
    Singh V; Kapoor R; Solanki KK; Singh G; Verma GR; Sharma SC
    Liver Int; 2007 Apr; 27(3):347-52. PubMed ID: 17355456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ preservation in the management of pancreatic cancer.
    Cellini N; Morganti AG; Ziccarelli P; Marucci L; Smaniotto D
    Rays; 1997; 22(3):484-9. PubMed ID: 9446955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-fluorouracil-based chemoradiation in unresectable pancreatic carcinoma: Phase I-II dose-escalation study.
    Morganti AG; Valentini V; Macchia G; Mattiucci GC; Costamagna G; Deodato F; Smaniotto D; Luzi S; Balducci M; Barbi S; Perri V; Trodella L; Cellini N
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1454-60. PubMed ID: 15275732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma.
    O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.